AbCellera Biologics Inc. ABCL Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s accrued expenses?
- AbCellera Biologics Inc. (ABCL) reported accrued expenses of $3.93M in Q1 2026.
- How has AbCellera Biologics Inc.'s accrued expenses changed year-over-year?
- AbCellera Biologics Inc.'s accrued expenses increased by 23.2% year-over-year, from $3.19M to $3.93M.
- What is the long-term trend for AbCellera Biologics Inc.'s accrued expenses?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s accrued expenses has grown at a 18.6% compound annual growth rate (CAGR), from $6.45M to $10.76M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.